- Global Pharma News & Resources

Global Orphan Drug Market 2021:Outlook,Trends,Covid-19 Impact,Future Aspect Analysis 2026| | Top Companies-AbbVie, AstraZeneca, Baxter, Eli Lilly and Company, Johnson & Johnson Services Inc., Merck KGaA

The Orphan Drug market report is a comprehensive analysis on the study of Industry. The report provides with all the CAGR values for the forecast period of 2019-2026. The Orphan Drug market research report is a resource, which provides current as well as upcoming technical and financial details of the industry to 2026.This analysis gives an examination of various segments that are relied upon to witness the quickest development amid the estimate forecast frame. Recognize the most recent improvements, share, and systems utilized by the significant market.

Download Free Sample (350 Pages PDF, Full TOC, List of Tables & Figures, and Chart) Report @

Global orphan drug market is rise gradually to an estimated value of USD 326.25 billion by 2026 registering a CAGR of 8.5% in the forecast period of 2019-2026. Growing number of orphan diseases, accelerating novel therapies and orphan drug development programs and exclusive incentives from the government are the key factors for market growth.

Few of the major competitors currently working in the global  orphan  disease market are

  • Hoffmann-La Roche Ltd.,
  • Novartis AG, Pfizer Inc.,
  • AbbVie, AstraZeneca, Baxter,
  • Eli Lilly and Company,
  • Johnson & Johnson Services Inc.,
  • Merck KGaA,
  • Novo Nordisk A/S, Bristol-Myers Squibb Company,
  • Alexion Pharmaceuticals,
  • Kyowa Hakko Kirin Co., Ltd.,
  • Amgen Inc., Biogen,
  • Celldex Therapeutics,
  • GlaxoSmithKline plc., Eisai Co., Ltd.,
  • Takeda Pharmaceutical Company Limited,
  • Vertex Pharmaceuticals Incorporated (US)

Market Drivers

  • Increase in prevalence rate of orphan disease worldwide
  • Expansion of product pipeline by launching new drugs
  • Impact of developments in pharmacogenomics
  • Government initiatives for the development
  • Granting exclusive incentives
  • Increase in the rate of R&D initiatives is driving orphan disease drug market

Market Restraints

  • Effective treatment is either unavailable or unaffordable
  • Lack of awareness among the patient and physician about Orphan disease treatment
  • High prices are associated with these drug development

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Research Methodology

Part 04: Orphan Drug Market Landscape

  • Market Ecosystem
  • Market Characteristics
  • Market Segmentation Analysis

Part 05: Market Sizing

  • Market Definition
  • Market Sizing 2019
  • Market Size And Forecast 2019-2026

Part 06: Customer Landscape

Part 07: Orphan Drug Market Regional Landscape

  • Geographical Segmentation
  • Regional Comparison
  • Americas – Market Size And Forecast 2019-2026
  • EMEA – Market Size And Forecast 2019-2026
  • APAC – Market Size And Forecast 2019-2026

Part 08: Decision Framework

Part 09: Drivers And Challenges

  • Market Drivers
  • Market Challenges

Part 10: Orphan Drug Market Trends

Part 11: Vendor Landscape

  • Overview
  • Landscape Disruption
  • Vendors Covered
  • Vendor Classification
  • Market Positioning Of Vendors

Get Latest Free TOC of This Report @

Other Important Orphan Drug Market Data Available In This Report:

  • Market share and year-over-year growth of key players in promising regions
  • Emerging opportunitiescompetitive landscaperevenue and share of main manufacturers.
  • Key performing regions (APAC, EMEA, Americas) along with their sub-regions are detailed in this report.
  • Strategic recommendations, forecast & growth areas of the Orphan Drug
  • This report discusses the market summary, market scope& gives a brief outline of the Orphan Drug Market
  • Challenges for the new entrants, trends& market drivers.
  • Competitive developments such as expansionsagreements, new product launches & acquisitions.

Segmentation: Global Orphan Drug Market

Orphan Drug Market By Disease Type

  • Oncology disease
  • Metabolic Disease
  • Hepatology
  • Immunology
  • Infection
  • Neurology


Orphan Drug Market By Drug Type

  • Biological
  • Non-Biological
  • Others

Orphan Drug Market By Indication Type

  • Non-Hodgkin Lymphoma
  • Acute Myeloid Leukemia
  • Cystic Fibrosis
  • Glioma
  • Pancreatic Cancer
  • Ovarian Cancer
  • Multiple Myeloma
  • Duchenne Muscular Dystrophy
  • Renal Cell Carcinoma
  • Others

Orphan Drug Market By Drug class

  • Lenalidomide
  • Rituximab
  • Glatiramer Acetate
  • Nivolumab
  • Interferon Beta-1a
  • Ibrutinib
  • Cinacalcet Hydrochloride
  • Imatinib Mesylate
  • Bortezomib
  • Sodium Oxybate
  • Others

Orphan Drug Market By Therapy

  • Medication
  • Surgery
  • Others

Orphan Drug Market By Route of administration

  • Oral
  • Intravenous
  • Others

Orphan Drug Market By End users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Orphan Drug Market By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

For More Information or Query or, Customization before Buying Visit @

Study Objectives Of Orphan Drug Market

  • To provide detailed analysis of the market structure along with forecast for the next 7 years
  • To study the factors affecting the Orphan Drug Market Growth
  • To provide country level analysis of the Orphan Drug Market by their market size & future perspective
  • To provide revenue forecast of the market segments & sub-segments w.r.t to three key region of APAC,EMEA & Americas
  • To study & predict the accurate future market size, share during the period 2019-2026
  • To provide the challenges & restraints faced by the new entrants of Orphan Drug Market along with the threat of substitutes & threats of rivalry
  • To study, track & analyze competitive developments such as joint ventures, strategic alliance, mergers, acquisitions & new product developments

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.


Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475


This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 20-Jan-2021